DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Stock

Certificat

DE000ME9P869

Market Closed - Börse Stuttgart 14:19:07 2024-06-12 EDT
0.12 EUR -17.81% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month-50.00%
1 month-58.62%
Date Price Change
24-06-12 0.12 -17.81%
24-06-11 0.146 -10.43%
24-06-10 0.163 -16.41%
24-06-07 0.195 -3.47%
24-06-06 0.202 -0.98%

Delayed Quote Börse Stuttgart

Last update June 12, 2024 at 02:19 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME9P86
ISINDE000ME9P869
Date issued 2024-03-06
Strike 100 $
Maturity 2024-12-20 (191 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.4
Lowest since issue 0.12
Spread 0.008
Spread %6.35%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
61.69 USD
Average target price
88.55 USD
Spread / Average Target
+43.55%
Consensus